1 – 15 of 38
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Quality assessment of radiotherapy in the prospective randomized SENOMAC trial
(
- Contribution to journal › Article
- 2023
-
Mark
Protocol for the T-REX-trial : Tailored regional external beam radiotherapy in clinically node-negative breast cancer patients with 1-2 sentinel node macrometastases - An open, multicentre, randomised non-inferiority phase 3 trial
(
- Contribution to journal › Article
-
Mark
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy : A systematic review and meta-analysis
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Prospective Clinical Feasibility Study for MRI-Only Brain Radiotherapy
(
- Contribution to journal › Article
-
Mark
MRI-only radiotherapy of gliomas – a prospective implementation study.
(
- Contribution to journal › Published meeting abstract
-
Mark
Evalutation of two commercial deep learning OAR segmentation models for prostate cancer treatment
2022) ESTRO 2022(
- Contribution to conference › Abstract
-
Mark
Pelvic U-Net : multi-label semantic segmentation of pelvic organs at risk for radiation therapy anal cancer patients using a deeply supervised shuffle attention convolutional neural network
(
- Contribution to journal › Article
-
Mark
Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial
(
- Contribution to journal › Article
- 2021
-
Mark
Clinical validation of a commercially available deep learning software for synthetic CT generation for brain
(
- Contribution to journal › Article
-
Mark
Quality assessment of locoregional breast cancer radiotherapy in the international SENOMAC-trial.
(
- Contribution to journal › Published meeting abstract
- 2020
-
Mark
MRI-only based treatment with a commercial deep-learning generation method for synthetic CT of brain
(
- Contribution to conference › Abstract
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Expression of HIF-1α is related to a poor prognosis and tamoxifen resistance in contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes
(
- Contribution to journal › Article
-
Mark
Comparative treatment planning study for mediastinal Hodgkin’s lymphoma : impact on normal tissue dose using deep inspiration breath hold proton and photon therapy
(
- Contribution to journal › Article